News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Triplex, a Diagnostics Company, Lands $50 Million From RRJ Capital


9/10/2012 10:19:09 AM

by Richard Daverman, PhD

September 7, 2012 -- Triplex International Biosciences (China) Co., a Xiamen maker of medical diagnostic reagents and instruments, received a $50 million capital infusion from private-equity firm RRJ Capital. According to unnamed sources, the investment will buy a stake in Triplex that is somewhere in the 11% to 19% range. Triplex makes diagnostic tests for hepatitis B and C and various forms of cancer. RRJ Capital is based in Hong Kong and Singapore. More details....


Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES